Gain Therapeutics announces Phase 1b clinical trial approval in Australia for GT-02287 to evaluate safety in Parkinson's disease patients. Gain Therapeutics, Inc. has received approval to start ...
Michael J Fox has shared his frank thoughts about death ahead of his new role as a character with Parkinson's disease, a degenerative neurological condition.Fox, who became a pop culture icon for his ...
IND submitted to FDA and HREC approval obtained in Australia; global trial initiation in Q4 2025 HUNTSVILLE, AL, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: ...
Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –– New analysis increases overall confidence in the ...
Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations –MELBOURNE, Australia and SAN ...
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced the successful acquisition of PKG Health, a leading innovator in movement disorder ...
Scientists have, for the first time, directly visualised and quantified the protein clusters believed to trigger Parkinson's, marking a major advance ...
There's a growing movement of people with Parkinson's putting on the gloves, and taking boxing classes to counter the effects ...
The campus is the first site with FDA authorization to use this investigational device during brain surgery to study executive functionDoctors at the ...